admin, Author at PsyNews.com

Home Authors Posts by admin

2176 POSTS 0 COMMENTS

https://psynews.com

Psychedelic Bulletin: DEA Again Increases Psychedelics Production Quotas; MindMed Announces Microdosing...

Numinus to Begin Trading on the OTC Under Symbol NUMIF

Tryp Therapeutics Provides Update on Clinical Hold for Phase 2a Study...

PTSF85 – Ahmad Doroudian, Ph.D. of BetterLife Pharma and Dr. Abid...

Algernon Announces Positive Feedback on its Planned Phase 1/2a DMT Human...

Wesana Health Clinics Surpass 4,000 Administered Ketamine Treatments

MYND Diagnostics Commences Clinical Research on Multiple Sclerosis Biomarker Test

Small Pharma Strengthens Board With Appointment of Paul Maier as Independent...

Silo Pharma and Strategic Partner Zylo Therapeutics Begin Development Process for...

Eyes on Oregon, a Psychedelics Today Podcast with Jon Dennis and...

1...179180181...218 Page 180 of 218

Colorado’s Psilocybin Supply Chain Complete: First Testing Lab Licensed, Sessions Could...

Pα+ Psychedelic Bulletin #196: Otsuka Eyes Psychedelic Future in Japan; First...

EXCLUSIVE: Heroic Hearts and Healing Breakthrough Merge to Expand Stateside Psychedelic...

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

admin